Virtue Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2019

Location

Suzhou Jiangsu China

Primary Industry

Medical Devices & Equipment

About

Established in 2019 and based in Suzhou, China, Virtue operates as an in vitro diagnostic technology and product developers that provides in vitro diagnostic technology and product. PerkinElmer is the strategic partner of the company. The company has promoted triple quadrupole mass spectrometry detection system QSight 420MD in 2021. The company provides clinical solution from early screening, diagnosis, treatment monitoring to prognosis management. The company focuses on infectious diseases, tumors, women and children, and chronic diseases. The company also provides platform that includes clinical mass spectrometry, panoramic pathology and molecular diagnosis. The company will put the funding towards technology platform R&D and in vitro diagnosis business expansion.

Current Investors

Lilly Asia Ventures, PerkinElmer, Inc., Sequoia Capital

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic Equipment

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.